Aptamer Group plc (APTA.L) Research

Aptamer Group plc, an international company headquartered in York, United Kingdom, specializes in providing advanced binders for applications spanning research, diagnostics, and therapeutics. Their innovative binder technology is engineered to resolve challenges often associated with traditional molecular tools, such as antibodies, offering crucial solutions to bioprocessing, diagnostic, and pharmaceutical scientists. Established in 2014, the company primarily serves pharmaceutical corporations, diagnostic development firms, and various research institutes.

Market snapshot

Symbol
APTA.L
Price
$0.53
Day change
+10.53%
Market cap
$15.4M
P/E ratio
-8.75x
52-week range
0.301-1.57
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 4 months

Peer companies

  • Arecor Therapeutics plc (AREC.L)
  • Fusion Antibodies plc (FAB.L)
  • Futura Medical plc (FUM.L)
  • Genflow Biosciences plc (GENF.L)
  • Inspiration Healthcare Group plc (IHC.L)
  • Novacyt S.A. (NCYT.L)
  • Oxford BioDynamics Plc (OBD.L)
  • Poolbeg Pharma PLC (POLB.L)

Open Aptamer Group plc (APTA.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.